Thinking Out-of-the-Box: A Non-Standard Application of Standard Pulse-Oximetry and Standard Near-Infrared Spectroscopy in a COVID-19 Patient즉시 사용 가능: COVID-19 환자의 표준 맥박 산소 측정 및 표준 근적외선 분광법의 비표준 적용Case Reports Published on 2020-10-092022-09-12 Journal: Journal of Intensive Care Medicine [Category] MERS, SARS, 진단, [키워드] Adequacy application Clinical finding COVID COVID-19 COVID-19 patient Covidien expected extremities feasibility hemoglobin infrared spectroscopy knowledge lingual material mechanical ventilation near-infrared spectroscopy NIRS oral cavity oxygenated Oxygenation performed Prone position pulse pulse oximetry saturation Spectroscopy Standard suggested thinking thrombosis tissue tissues tongue unlikely USA Venous thrombosis viability vitality were recorded [DOI] 10.1177/0885066620965167 PMC 바로가기 [Article Type] Case Reports
Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care dataResearch Article Published on 2020-09-222022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] 95% CI 95%CI adjusted Admission collected Comparative Course COVID-19 death Deterioration died disease Effect effective elevated Endotracheal intubation feature glucocorticoid high-risk population IMPROVE inflammatory activity Inflammatory marker intubation objective outcome Patient patients with COVID-19 Pneumonia Prognosis prognosis of patient pulse receiving Result risk routine care second severe coronavirus disease Spain SpO2/FiO2 suffered with COVID-19 [DOI] 10.1371/journal.pone.0239401 PMC 바로가기 [Article Type] Research Article
Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?Review Published on 2020-09-212022-10-31 Journal: Mediterranean Journal of Rheumatology [Category] COVID-19, [키워드] “cytokine storm” ACE2 receptor addition Against anti-cytokine antimalarial Asymptomatic cause clinical trial Colchicine Course COVID-19 COVID-19 infection COVID-19 symptoms current cytokine Cytokine storm Cytokines death develop drug dysregulated elderly expressed high risk Hydroxychloroquine IL-1 IL-6 immune system immunoglobulins intensive care intravenous male medical condition novel occur Other Patient patients plethora positive-sense single-stranded RNA pro-inflammatory cytokine producing Protein pulse reduce respiratory cells SARS-CoV-2 selected severe complications severely infected patient shown smoker spike Spike protein therapy Tocilizumab Treatment ventilatory support virus [DOI] 10.31138/mjr.31.3.259 PMC 바로가기 [Article Type] Review
Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19Immunology Published on 2020-09-022022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome Admission analyzed association cardiovascular disease CD3 CD8 Clinical characteristics Clinical data conducted coronavirus coronavirus disease Course COVID-19 Cytokines discharge disease course evaluated Factor first test identify IL-10 IL-6 Illness severity immune damage in-depth analysis Infection Inflammation Inflammatory cytokines information Logistic regression Male sex marker measure Neutrophil-to-lymphocyte ratio Neutrophil-to-lymphocyte ratios objective pathological mechanism Patient positively correlated predict pulse Ratio recruited Result risk factor SARS-CoV-2 severity severity and course of non-mild COVID-19 significantly subset T lymphocyte the disease underlying disease was collected Wuhan [DOI] 10.3389/fimmu.2020.02160 PMC 바로가기 [Article Type] Immunology
Prediction model and risk scores of ICU admission and mortality in COVID-19COVID-19에서 중환자실 입원 및 사망률의 예측 모델 및 위험 점수Research Article Published on 2020-07-302022-08-13 Journal: PLoS ONE [Category] COVID-19, Medicine and Health Sciences, MERS, SARS, [키워드] Accuracy Admission age Analysis AUC Cardiopulmonary characteristic chronic obstructive chronic obstructive pulmonary disease Clinical characteristics clinical variable Comorbidities Comorbidity COVID-19 COVID-19 patients dataset death demographics develop evaluated heart failure heart rate hospitalized patient ICU ICU admission identify independent initial intensive care intensive care unit Laboratory test Laboratory tests laboratory-confirmed Laboratory-confirmed COVID-19 Lactate lactate dehydrogenase Logistic regression lymphocyte Lymphocyte count medical record medical records Mortality mortality group obstructive pulmonary disease outcome outcomes oxygen oxygen saturation performance performed physician predict predicted prediction Primary outcomes procalcitonin pulmonary disease pulse receiver operating characteristic retrospective retrospective review risk risk score Risk scores ROC selected significant variable smoking splitting variables was used with COVID-19 [DOI] 10.1371/journal.pone.0236618 PMC 바로가기 [Article Type] Research Article
Immune Thrombocytopenia Purpura Secondary to COVID-19Internal Medicine Published on 2020-07-092022-10-31 Journal: Cureus [Category] COVID-19, [키워드] abnormality Administered allergies B12 back pain body aches C-reactive protein Complete complete blood count COVID COVID-19 D-dimer Dexamethasone diarrhea discharge discharged dose doses elevated essential hypertension fatigue female fevers fibrinogen Headaches hematologic hospital hyperlipidemia immune thrombocytopenia purpura Infection INR International lab Lactate leukopenia Nasopharyngeal swab nasopharyngeal swab PCR normalized past medical history Patient PCR peripheral Platelet polymerase chain positive prothrombin pulse purpura resolution of symptom schistocyte secondary to Shortness of breath the patient thrombocytopenia transfused treated Treatment was obtained was tested [DOI] 10.7759/cureus.9083 PMC 바로가기 [Article Type] Internal Medicine
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical CasesEmergency Medicine Published on 2020-07-072022-10-31 Journal: Cureus [Category] COVID-19, [키워드] changes clinical clinical manifestation Combination Corticosteroids COVID-19 CRS Cytokine release syndrome Efficacy and safety Evidence high-dose methylprednisolone Immunoglobulin intravenously life-threatening life-threatening coronavirus disease Methylprednisolone Patient patients persistence pulmonary CT pulse pulse therapy Randomized controlled trial report required Respiratory failure Safe SARS-CoV-2 therapy Treatment treatment regimen virus [DOI] 10.7759/cureus.9038 PMC 바로가기 [Article Type] Emergency Medicine
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection MortalityAntiviral Agents Published on 2020-06-222022-10-27 Journal: Antimicrobial Agents and Chemotherapy [Category] COVID-19, [키워드] acute respiratory syndrome adjusted confidence interval Control Controlled coronavirus coronavirus disease COVID-19 determine glucocorticoid hazard ratio hospital hospitalized patient Impact in-hospital mortality inclusion criteria initial initial treatment interquartile range log rank test median time Methylprednisolone Mortality not different Odds ratio Patient patients treated patients with SARS-CoV-2 performed Pneumonia pulse Rate reduced regimen retrospective cohort study risk reduction SARS-CoV-2 single-center Spain steroid steroid treatment Steroids study period Support survival survival time symptom onset treated Treatment university hospital use of steroid with COVID-19 [DOI] 10.1128/AAC.01168-20 PMC 바로가기 [Article Type] Antiviral Agents
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection MortalityAntiviral Agents Published on 2020-06-222022-10-27 Journal: Antimicrobial Agents and Chemotherapy [Category] Coronavirus, COVID-19, MERS, [키워드] acute respiratory syndrome adjusted confidence interval Control Controlled coronavirus coronavirus disease COVID-19 determine glucocorticoid hazard ratio hospital hospitalized patient Impact in-hospital mortality inclusion criteria initial initial treatment interquartile range log rank test median time Methylprednisolone Mortality not different Odds ratio Patient patients treated patients with SARS-CoV-2 performed Pneumonia pulse Rate reduced regimen retrospective cohort study risk reduction SARS-CoV-2 single-center Spain steroid steroid treatment Steroids study period Support survival survival time symptom onset treated Treatment university hospital use of steroid with COVID-19 [DOI] 10.1128/AAC.01168-20 PMC 바로가기 [Article Type] Antiviral Agents
Just the Facts: Protected code blue – Cardiopulmonary resuscitation in the emergency department during the coronavirus disease 2019 pandemicJust the Facts Published on 2020-04-242022-10-31 Journal: CJEM [Category] Coronavirus, SARS, [키워드] Cardiac arrest Cardiopulmonary resuscitation chest pain coronavirus disease cough COVID-19 emergency medical service Fever Mild pandemic Patient PROTECT protected code blue pulse Shortness of breath SpO2 the patient Vital [DOI] 10.1017/cem.2020.379 PMC 바로가기 [Article Type] Just the Facts